Do Patients Understand The Term ‘Median’ In Advertising? US FDA Aims To Find Out

In first Rx advertising research project of 2023, FDA will survey consumers on how they interpret quantitative claims in DTC ads. Lilly questions design of another study examining relative importance of product information, citing FDA comments at tanezumab advisory committee.

Ads
FDA conducting survey of consumer's interpretation of quantitative claims in advertising • Source: Shutterstock

More from Marketing & Advertising

More from Compliance